PubMed
PubMed® comprises more than 36 million citations for biomedical literature from MEDLINE, life science journals, and online books. Citations may include links to full text content from PubMed Central and publisher web sites.
PubMed® comprises more than 36 million citations for biomedical literature from MEDLINE, life science journals, and online books. Citations may include links to full text content from PubMed Central and publisher web sites.
AbstractBackground. Obinutuzumab, a new-generation anti-CD20 monoclonal antibody, was originally emerged to overcome resistance to rituximab in B-cell mali
The relationship between individual lipoprotein particle subclasses and lipid-related traits and risk of chronic kidney disease (CKD) in general population is unclear. Using data from…
Access to a variety of continuing education resources. Evidence-based clinical practice guidelines.* Scientific research grants and fellowships. Educational stipends.* Access to clinical tools and resources.…
After guideline changes, aspirin use dropped off overall, even for higher-risk patients in whom it might still be considered.
VA for Characterizing the Origins of Primary Aldosteronism
This week, we will discuss the origins of primary hyperaldosteronism in normotensive patients. Could this undetected anomaly be the cause of idiopathic hypertension and CKD?
This cohort study evaluates if transient ischemic attack is an independent risk associated with cognitive decline when controlling for vascular and demographic factors.
“The Pediatric Nephrology Match: A Fellow’s Perspective on a Subspecialty Under Pressure” published on 07 Feb 2025 by American Society of Nephrology.
“Symptom Management in CKD” published on 07 Feb 2025 by American Society of Nephrology.
“A New Step Forward in Gene Therapy Research for Kidney Diseases” published on 07 Feb 2025 by American Society of Nephrology.